PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

AMO Pharma reveals data from myotonic dystrophy study

Clinically significant results have emerged from the trial evaluating the company’s AMO-02 candidate. AMO Pharma Limited, a company concentrating on rare childhoo...
Continue Reading →
News

Ariceum doses first patient with satoreotide

The treatment targets extensive stage small cell lung cancer and aims to boost therapeutic impact. Ariceum Therapeutics, a company developing products for the tre...
Continue Reading →
News

Neuroplast spinal cord injury study milestone

The trial analyses the impact of its ‘Neuro-Cells’ among patients with traumatic spinal cord injuries. Neuroplast, a company concentrating on cell-based treatment...
Continue Reading →
News

Tower continues innovation streak with new product launch at CPHI Barcelona

Temperature-controlled container specialist, Tower Cold Chain will be exhibiting its latest concept and products at the world’s largest pharmaceutical event, CPHI. ...
Continue Reading →
News

TherageniX to receive powdered gene therapy grant

The funding will boost the University of Nottingham spinout’s development of bone regeneration treatment. TherageniX, a company developing a dry powder gene thera...
Continue Reading →
News

Intelligent OMICS partners with Janssen on AI-driven research

The AI platform and expertise will be combined to discover novel targets for haematological cancers. Intelligent OMICS, a biotechnology company that applies artif...
Continue Reading →
News

Twist Bioscience and Ono Pharmaceutical collaborate

The partnership will discover and develop novel antibodies for a range of autoimmune diseases. Twist Bioscience, a synthetic DNA company, and Ono Pharmaceutical h...
Continue Reading →
News

UCB announces approval of Bimzelx

The therapy is used to treat patients with psoriatic arthritis and axial spondyloarthritis. UCB has announced that the Medicines and Healthcare products Regulator...
Continue Reading →
News

Novartis reveals vital Leqvio data

The therapy involves treating individuals with atherosclerotic cardiovascular disease. Novartis has announced new long-term data from its ORION-8 clinical trial. ...
Continue Reading →
News

BIO-Europe®

BIO-Europe® has grown to be recognized as Europe’s flagship partnering event. In 2022, the event made its highly anticipated return to in-person, after a two-yea...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026